Overview
Pellagra is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Treatments & Interventions
Research Evidence
Peer-reviewed studies linked via MeSH term "Pellagra" from the MEDLINE/PubMed database.
Sort:
Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature.
[object Object] · Altern Med Rev · 2003
PMID: 12777163Meta-Analysis
The Promise of Niacin in Neurology.
[object Object], [object Object], [object Object] · Neurotherapeutics · 2023
Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease.
[object Object], [object Object], [object Object] · Cells · 2023
COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?
[object Object] · Int J Mol Sci · 2022
Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra.
[object Object], [object Object], [object Object] · Photodermatol Photoimmunol Photomed · 2021
PMID: 33471377Review
Pathophysiology and clinical management of pellagra - a review.
[object Object], [object Object], [object Object] et al. · Folia Med Cracov · 2021
PMID: 34882669Review
[Cutaneous manifestations of nutritional deficiencies].
[object Object], [object Object], [object Object] · Rev Med Suisse · 2019
PMID: 31746568Review
Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.
[object Object], [object Object], [object Object] et al. · Br J Dermatol · 2017
PMID: 27510322Review
Pellagra's Three Ds: Dermatology, Death, and Dracula.
[object Object], [object Object] · JAMA Dermatol · 2015
PMID: 26352123Review
[Niacin deficiency and cutaneous immunity].
[object Object], [object Object] · Nihon Rinsho Meneki Gakkai Kaishi · 2015
PMID: 25765687Review
Search all PubMed articles for Pellagra
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Vitamin B3 deficiency
Very frequent (80-99%)HP:0100497
Altered consciousness or cognition
Frequent (30-79%)HP:0031258
Cachexia
Frequent (30-79%)HP:0004326
Cheilitis
Frequent (30-79%)HP:0100825
Cognitive deficits
Frequent (30-79%)HP:0100543
Cutaneous photosensitivity
Frequent (30-79%)HP:0000992
Deglutition disorder
Frequent (30-79%)HP:0002015
Depressive episode
Frequent (30-79%)HP:0000716
Epidermal hyperkeratosis
Frequent (30-79%)HP:0000962
Gastritis
Frequent (30-79%)HP:0005263
Gingivostomatitis
Frequent (30-79%)HP:0010280
Headache
Frequent (30-79%)HP:0002315
Inflammation of the tongue
Frequent (30-79%)HP:0000206
Intestinal malabsorption
Frequent (30-79%)HP:0002024
Irregular hyperpigmentation
Frequent (30-79%)HP:0007400
Lingual hyperplasia
Frequent (30-79%)HP:0000158
Loss of appetite
Frequent (30-79%)HP:0004396
Malnutrition
Frequent (30-79%)HP:0004395
Nausea
Frequent (30-79%)HP:0002018
Pain
Frequent (30-79%)HP:0012531
Progressive dementia
Frequent (30-79%)HP:0000726
Schizophrenia
Frequent (30-79%)HP:0100753
Sensory hallucination
Frequent (30-79%)HP:0000738
Skin bullae
Frequent (30-79%)HP:0008066
Skin rash
Frequent (30-79%)HP:0000988
Tiredness
Frequent (30-79%)HP:0012378
Vomiting
Frequent (30-79%)HP:0002013
Xerosis
Frequent (30-79%)HP:0000958
Achlorhydria
Occasional (5-29%)HP:0032448
Cheekbone rash
Occasional (5-29%)HP:0025300
Quick Facts
- SNOMED CT
- 418186002
- UMLS CUI
- C0030783
- Fully Specified Name
- Pellagra (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
- Known Treatments
- 8
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.